My account
Injectables Orals Peptides Human Growth Hormone SARMs
Sign in
A
Anastrozole
B
Bacteriostatic water Boldenone undecylenate
C
Clenbuterol Clomiphene citrate Cabergoline
D
Drostanolone enanthate Drostanolone propionate Dehydroepiandrosterone (DHEA)
E
Erythropoietin Exemestane
F
Fluoxymesterone
H
Human chorionic gonadotropin Human growth hormone (HGH)
L
Liothyronine sodium
M
Mecasermin Meldonium Mesterolone Methandienone Methenolone acetate Methenolone enanthate Melanotan-2
N
Nandrolone decanoate Nandrolone phenylpropionate
O
Oxandrolone Oxymetholone
S
Sildenafil citrate Stanozolol
T
Trenbolone enanthate Trestolone acetate Trenbolone acetate Testosterone undecanoate Testosterone propionate Testosterone base and suspension Tadalafil citrate Testosterone cypionate Testosterone enanthate Tamoxifen citrate Turinabol
Y
Yohimbine
Show 164 results
Manufacturers
Categories
Substances
Disagree
Home Beligas Pharmaceuticals Beligas Pharmaceuticals
Tirzepatide
Tirzepatide - Beligas Pharmaceuticals

Tirzepatide - Beligas Pharmaceuticals

Brand:
Beligas Pharmaceuticals
Category:
Peptides
Substance:
Tirzepatide
Package:
10 mg
Price:
0
See options
Product Overview
Tirzepatide is a novel peptide that mimics two natural hormones, GLP-1 and GIP, responsible for regulating blood sugar and appetite. Unlike earlier drugs that target just one pathway, Tirzepatide combines both actions to deliver enhanced metabolic effects. It improves insulin response after meals, slows digestion, and reduces hunger. These combined effects support better blood glucose control and significant weight reduction. Its dual mechanism has made it a standout therapy for managing type 2 diabetes and obesity.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tirzepatide by Beligas Pharmaceuticals, consult with your doctor or healthcare professional.

Explore More Products
Reviews
Leave Review
FAQ
What receptors does Tirzepatide target?
Tirzepatide stimulates GLP‑1 and GIP pathways, improving glucose control and lipid metabolism simultaneously.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

How does Tirzepatide influence appetite?
Tirzepatide reduces appetite by acting on central satiety signals and delaying gastric emptying.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.

Can Tirzepatide improve inflammation markers?
Yes, Tirzepatide indirectly lowers systemic inflammation through weight loss and insulin sensitivity improvements.
References:

Gallwitz, B., 2022. Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity. Frontiers in Endocrinology.